Skip to content
Search

Latest Stories

Type 2 Diabetes Path to Remission Programme to be rolled out across England

Type 2 Diabetes Path to Remission Programme to be rolled out across England

Over 1,150 people with type 2 diabetes and obesity or overweight in the West Midlands have benefited from this programme

NHS England is expanding the Type 2 Diabetes Path to Remission Programme across the country from April 2024, following the successful pilot launch in the Midlands.


A joint initiative between NHSE and Diabetes UK, the programme offers a low calorie, total diet replacement treatment for individuals who are living with type 2 diabetes and obesity or overweight.

More than 1,150 patients in the West Midlands have joined the programme and benefited from it since its introduction in 2020 until February 2024.

Previously known as the NHS Low Calorie Diet Programme, this evidence-based intervention is aimed at reversing diabetes and maintaining weight loss in the long term.

“This is such a great chance for people to take control of their health and to put their type 2 diabetes into remission,” said Professor Vinod Patel, West Midlands Clinical Lead for NHS England (Midlands) for Diabetes.

Peter Shorrick, head of Midlands and East at Diabetes UK, explained that achieving remission can help reduce the risk of developing serious problems with the eyes, feet, or heart in many patients with type 2 diabetes, while also providing hope for a medication-free future.

“People in remission say it’s life changing and we funded research that shows that this programme works.

“Our aim is to support people to go on the Path to Remission Programme and achieve results safely, complementing it with our advice on a range of issues from maintaining a healthy diet, to exercise, mental health and the importance of peer-to-peer support to provide a holistic approach,” he added.

This programme is based on research that found a 3-month specially formulated ‘soup and shake’ diet, coupled with healthy lifestyle support, helped people living with type 2 diabetes and obesity or overweight to lose over 10kg (1st  5lbs) in weight, improve their blood glucose levels, reduce diabetes-related medication and achieve remission of type 2 diabetes in almost half of the participants.

People aged 18 – 65 years who have been diagnosed with type 2 diabetes within the last six years, and have a BMI over 27 kg/m2 (for individuals from White ethnic groups) or over 25 kg/m2 (for individuals from Black, Asian and other ethnic groups) are eligible to participate in the NHS Type 2 Diabetes Path to Remission Programme.

James from Birmingham has lost 95kg (54 per cent of his body weight) since starting the programme in 2021.

“I now weigh 82kg. With a Hb1Ac (average blood glucose) of 29, my diabetes is in remission and my GP has advised me that I don’t need any diabetes treatment which is fantastic,” James said.

He was referred to the programme by a nurse practitioner from his GP surgery due to difficulties tolerating his medications. At that time, his weight was 177kg (27st 8 lbs).

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less